Dendritic ZSM-5 zeolites as highly active catalysts for the valorization of monoterpene epoxides.

Dendritic ZSM-5 zeolites were investigated in the isomerization of monoterpene epoxides, including limonene-1,2-epoxide (LE), α-pinene epoxide, and β-pinene epoxide, which yields high-value compounds used in fragrances, cosmetics, and pharmaceuticals. The fresh catalysts were thoroughly characterized using XRD, Ar physisorption, pyridine-FTIR, TEM, FTIR/DTBPyr, and Al MAS NMR. In comparison with conventional and hierarchical ZSM-5 materials, the dendritic zeolite with a crystallization time of 4 days (d-ZSM-5/4d) was the most active material, with a turnover frequency value of 4.

Electrospun Fibers for Use in Implantable Materials to Support Cell Therapy.

Hydrogels are a class of biomaterials that can provide a three-dimensional (3D) environment capable of mimicking the extracellular matrix of native tissues. In this chapter, we present a method to generate electrospun nanofibers for the purpose of reinforcing hydrogels. The addition of electrospun fibers can be used to improve the mechanical properties of hydrogels and broaden their range of applications.

Manufacturing and validation of small-diameter vascular grafts: A mini review.

The field of small-diameter vascular grafts remains a challenge for biomaterials scientists. While decades of research have brought us much closer to developing biomimetic materials for regenerating tissues and organs, the physiological challenges involved in manufacturing small conduits that can transport blood while not inducing an immune response or promoting blood clots continue to limit progress in this area. In this short review, we present some of the most recent methods and advancements made by researchers working in the field of small-diameter vascular grafts.

Biomaterials for direct cardiac repair-A rapid scoping review 2012-2022.

A plethora of biomaterials for heart repair are being tested worldwide for potential clinical application. These therapeutics aim to enhance the quality of life of patients with heart disease using various methods to improve cardiac function. Despite the myriad of therapeutics tested, only a minority of these studied biomaterials have entered clinical trials.